Bibliografías temáticas / Insulin-like growth factor-binding proteins / Artículos de revistas

Artículos de revistas sobre el tema "Insulin-like growth factor-binding proteins"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Insulin-like growth factor-binding proteins.
Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 21 de febrero de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Insulin-like growth factor-binding proteins".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Kostecká, Z. y J. Blahovec. "Animal insulin-like growth factor binding proteins and their biological functions". Veterinární Medicína 47, No. 2 - 3 (30 de marzo de 2012): 75–84. http://dx.doi.org/10.17221/5807-vetmed.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Resumen
Insulin-like growth factor (IGF-I, IGF-II) action is influenced by until today known eight forms of insulin-like growth factor binding proteins (IGFBPs). They have been obtained not only from some human and animal tissues and body fluids but also from conditioned medium of cell cultures. An important biological property of the IGFBPs is their ability to increase the circulating half-life of the IGFs. They are able to act as potentiators of cell proliferation. As IGFBPs bind to cell surfaces, they may act either to deliver the IGFs to those surfaces for activation of specific receptors or to activate cell responses independently of receptor activation. Phosphorylation, glycosylation and proteolysis of IGFBPs influence their affinity to IGFs. The IGFBPs in the role of inhibitors may block the activity of the IGFs and be used for antimitogenic therapy. In the last time measuring of IGFBPs levels can be used for diagnosis determination of some endocrine diseases or in differential diagnostics.
2

Lee, Chang Hoon, Chin Saeng Cho, Kyung-You Park, Joon Woo Kim, Gwan Won Lee, Byung Kwon Lee y Jae Soo Lee. "The Role of Insulin-Like Growth Factor I and Binding Protein in Cholesteatoma Fibroblasts". Journal of Clinical Otolaryngology Head and Neck Surgery 14, n.º 1 (mayo de 2003): 113–17. http://dx.doi.org/10.35420/jcohns.2003.14.1.113.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Purwana, Arie, Budiono Budiono, Jose RL Batubara y Muhammad Faizi. "Association of Growth Velocity with Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Children with a Vegan Diet". Journal of Biomedicine and Translational Research 6, n.º 1 (6 de febrero de 2020): 6–10. http://dx.doi.org/10.14710/jbtr.v6i1.5474.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Resumen
Background: The vegan diet in children provides the benefit of reducing the risk of being overweight and improving the fat profile. The risk that can occur in the provision of a vegan diet in children is anthropometric size below reference and low caloric intake. Growth hormone (GH) and Insulin like Growth Factors (IGFs) are powerful stimulators for longitudinal growth of bone and require insulin-like growth factor binding protein (IGFBPs) which acts as a transport protein for IGF-1. A vegan diet with lower calorie intake in children has lower IGF-I levels than children with an omnivorous diet.Objective: Examining the effect of vegan diets on IGF-1 levels, IGFBP-3 levels, and growth velocity.Methods: This study was done with a prospective cohort design. The study subjects were divided into two groups, namely the vegan group and the omnivorous group, then matched based on age and sex. During the study, anthropometric data collection, IGF-1 and IGFBP-3 levels measurements were done in both vegan children and omnivorous children.Results: During 6 months of observation, 22 subjects were divided into two groups, namely children with a vegan diet and children with an omnivorous diet. IGF-1 (ng / mL) in vegan children was 105.5 ± 47.3 compared to 102.7 ± 42.3 in omnivorous children with a value of p = 0.89. IGFBP-3 (ng / mL) in vegan children was 2146.4 ± 595.1 compared to 2142 ± 609.1 in omnivorous children with value of p = 0.99 and Growth Velocity (cm / 6 months) was 3.0 in vegan children (1.0-5.30), and 3.2 (2.6-6.5) in omnivorous children with value of p = 0.41.Conclusion:Children with vegan diet had IGF-1 level, IGFBP-3 level, and growth velocity that were the same as children with an omnivorous diet.
4

Leroith, Derek. "Insulin-like growth factor receptors and binding proteins". Baillière's Clinical Endocrinology and Metabolism 10, n.º 1 (enero de 1996): 49–73. http://dx.doi.org/10.1016/s0950-351x(96)80298-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Coverley, J. A. y R. C. Baxter. "Phosphorylation of insulin-like growth factor binding proteins". Molecular and Cellular Endocrinology 128, n.º 1-2 (abril de 1997): 1–5. http://dx.doi.org/10.1016/s0303-7207(97)04032-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Collet, Chris y Judith Candy. "How many insulin-like growth factor binding proteins?" Molecular and Cellular Endocrinology 139, n.º 1-2 (abril de 1998): 1–6. http://dx.doi.org/10.1016/s0303-7207(98)00078-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Bach, Leon A. "Insulin-like growth factor binding proteins 4-6". Best Practice & Research Clinical Endocrinology & Metabolism 29, n.º 5 (octubre de 2015): 713–22. http://dx.doi.org/10.1016/j.beem.2015.06.002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Baxter, Robert C. "Insulin-like growth factor binding proteins as glucoregulators". Metabolism 44 (octubre de 1995): 12–17. http://dx.doi.org/10.1016/0026-0495(95)90215-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Ferry Jr., Robert J., Ruben W. Cerri y Pinchas Cohen. "Insulin-Like Growth Factor Binding Proteins: New Proteins, New Functions". Hormone Research in Paediatrics 51, n.º 2 (1999): 53–67. http://dx.doi.org/10.1159/000023315.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Feld, Stella M. y Raimund Hirschberg. "Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome". Pediatric Nephrology 10, n.º 3 (1 de mayo de 1996): 355–58. http://dx.doi.org/10.1007/s004670050124.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Feld, Stella M. y Raimund Hirschberg. "Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome". Pediatric Nephrology 10, n.º 3 (junio de 1996): 355–58. http://dx.doi.org/10.1007/bf00866783.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Cara, José F. "Insulin-Like Growth Factors, Insulin-Like Growth Factor Binding Proteins and Ovarian Androgen Production". Hormone Research 42, n.º 1-2 (1994): 49–54. http://dx.doi.org/10.1159/000184145.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Rosen, Clifford J. "Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications". Clinical Chemistry 45, n.º 8 (1 de agosto de 1999): 1384–90. http://dx.doi.org/10.1093/clinchem/45.8.1384.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Resumen
Abstract The last decade has been characterized by a major investigative thrust into the physiology of two unique but ubiquitous peptides, insulin-like growth factor (IGF)-I and IGF-II. The regulatory systems that control the tissue bioactivity of the IGFs have been delineated, and subcellular signaling mechanisms have been clarified. Clearly, both tissue and circulating growth factor concentrations are important in defining the relationship between IGF-I and cell activity. Bone, liver, and circulatory IGF-I have received the most attention by investigators, in part because of the ease of measurement and the interaction with disease states such as osteoporosis. More recently, attention has focused on the role IGF-I plays in neoplastic transformation and growth. Two large prospective observational studies have demonstrated greater risk for prostate and breast cancer associated with high circulating concentrations of IGF-I. Animal models and in vitro studies confirm that there is a close, albeit complex, interaction between IGF-I signaling and bone turnover. This report will focus on: (a) IGF physiology, including IGF ligands, binding proteins, and proteases; (b) the relationship between IGF-I and bone mass in respect to risk for osteoporosis; (c) the heritable regulation of the IGF-I phenotype; and (d) the association between serum IGF-I and cancer risk. The IGFs remain a major area for basic and clinical investigations; future studies may define both diagnostic and therapeutic roles for these peptides or their related proteins in several disease states.
14

Ryu, Hye-Young, Hye-Jung Hwang, In-Hye Kim, Hong-Soo Ryu y Taek-Jeong Nam. "Effects of Glucose on Insulin-like Growth Factor Binding-5 Expression in Human Fibroblasts." Journal of Life Science 17, n.º 9 (30 de septiembre de 2007): 1224–31. http://dx.doi.org/10.5352/jls.2007.17.9.1224.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Hwa, V., Y. Oh y RG Rosenfeld. "Insulin-like growth factor binding proteins: a proposed superfamily". Acta Paediatrica 88, s428 (febrero de 1999): 37–45. http://dx.doi.org/10.1111/j.1651-2227.1999.tb14349.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Ranke, M. B. y M. Elmlinger. "Functional Role of Insulin-Like Growth Factor Binding Proteins". Hormone Research 48, n.º 4 (1997): 9–15. http://dx.doi.org/10.1159/000191304.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Holly, Jeff y Claire Perks. "The Role of Insulin-Like Growth Factor Binding Proteins". Neuroendocrinology 83, n.º 3-4 (2006): 154–60. http://dx.doi.org/10.1159/000095523.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Conover, Cheryl A. "Insulin-like growth factor-binding proteins and bone metabolism". American Journal of Physiology-Endocrinology and Metabolism 294, n.º 1 (enero de 2008): E10—E14. http://dx.doi.org/10.1152/ajpendo.00648.2007.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Resumen
Insulin-like growth factor-binding proteins (IGFBPs) are important regulators of bone metabolism. However, their precise roles are not fully understood, since IGFBPs can have both enhancing and inhibiting effects on IGF action, depending on context and posttranslational modifications, as well as IGF-independent effects. This review focuses on recent findings from cell culture, rodent models, and clinical studies concerning local IGFBP-2, IGFBP-4, and IGFBP-5 action in bone.
19

D??ez, Javier, Concepci??n Laviades, Eduardo Mart??nez, Mar??a J. Gil, Ignacio Monreal, Javier Fern??ndez y Jes??s Prieto. "Insulin-like growth factor binding proteins in arterial hypertension". Journal of Hypertension 13, n.º 3 (marzo de 1995): 349???356. http://dx.doi.org/10.1097/00004872-199503000-00011.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Monget, P., N. Besnard, C. Huet, C. Pisselet y D. Monniaux. "Insulin-Like Growth Factor-Binding Proteins and Ovarian Folliculogenesis". Hormone Research 45, n.º 3-5 (1996): 211–17. http://dx.doi.org/10.1159/000184790.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Rosenfeld, RG, H. Pham, P. Cohen, P. Fielder, SE Gargosky, H. Muller, L. Nonoshita y Y. Oh. "Insulin-like growth factor binding proteins and their regulation". Acta Paediatrica 83, s399 (abril de 1994): 154–58. http://dx.doi.org/10.1111/j.1651-2227.1994.tb13315.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Ferry, R., L. Katz, Adda Grimberg, P. Cohen y S. Weinzimer. "Cellular Actions of Insulin-Like Growth Factor Binding Proteins". Hormone and Metabolic Research 31, n.º 02/03 (enero de 1999): 192–202. http://dx.doi.org/10.1055/s-2007-978719.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Rechler, Matthew M. y David R. Clemmons. "Regulatory Actions of Insulin-like Growth Factor-binding Proteins". Trends in Endocrinology & Metabolism 9, n.º 5 (julio de 1998): 176–83. http://dx.doi.org/10.1016/s1043-2760(98)00047-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Chan, Kam y E. Martin Spencer. "General aspects of insulin-like growth factor binding proteins". Endocrine 7, n.º 1 (agosto de 1997): 95–97. http://dx.doi.org/10.1007/bf02778072.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Subramanian, Ashok, Anup Sharma y Kefah Mokbel. "Insulin-like growth factor binding proteins and breast cancer". Breast Cancer Research and Treatment 107, n.º 2 (5 de julio de 2007): 181–94. http://dx.doi.org/10.1007/s10549-007-9549-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Prosser, C. G. y R. D. McLaren. "Insulin-like growth factor binding proteins of equine serum". Biochemical and Biophysical Research Communications 189, n.º 3 (diciembre de 1992): 1255–60. http://dx.doi.org/10.1016/0006-291x(92)90208-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Bach, L. A., S. Hsieh, K. Sakano, H. Fujiwara, J. F. Perdue y M. M. Rechler. "Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6". Journal of Biological Chemistry 268, n.º 13 (mayo de 1993): 9246–54. http://dx.doi.org/10.1016/s0021-9258(18)98342-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Hodgkinson, S. C., J. R. Napier, G. S. G. Spencer y J. J. Bass. "Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins". Journal of Molecular Endocrinology 13, n.º 1 (1 de agosto de 1994): 105–12. http://dx.doi.org/10.1677/jme.0.0130105.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Grulich-Henn, J., J. Grulich-Henn, S. Spiess, S. Spiess, U. Heinrich, U. Heinrich, D. Schönberg, D. Schönberg, M. Bettendorf y M. Bettendorf. "Ligand Blot Analysis of Insulin-Like Growth Factor-Binding Proteins using Biotinylated Insulin-Like Growth Factor-I". Hormone Research in Paediatrics 49, n.º 1 (16 de diciembre de 1997): 1–7. http://dx.doi.org/10.1159/000023118.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Rey, F., F. M. Rodríguez, N. R. Salvetti, M. M. Palomar, C. G. Barbeito, N. S. Alfaro y H. H. Ortega. "Insulin-Like Growth Factor-II and Insulin-Like Growth Factor-Binding Proteins in Bovine Cystic Ovarian Disease". Journal of Comparative Pathology 142, n.º 2-3 (febrero de 2010): 193–204. http://dx.doi.org/10.1016/j.jcpa.2009.11.002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Tanaka, Reiko, Toshio Tsushima, Hitomi Murakami, Kazuo Shizume y Takao Obara. "Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors". World Journal of Surgery 18, n.º 4 (1994): 635–41. http://dx.doi.org/10.1007/bf00353784.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

King, Jeffery L. y Clyde Guidry. "Insulin-Like Growth Factor Binding Proteins Modulate Müller Cell Responses to Insulin-Like Growth Factors". Investigative Opthalmology & Visual Science 45, n.º 8 (1 de agosto de 2004): 2848. http://dx.doi.org/10.1167/iovs.04-0054.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Hintz, R. L. "Role of Growth-Hormone and Insulin-Like Growth-Factor-Binding Proteins". Hormone Research 33, n.º 2-4 (1990): 105–10. http://dx.doi.org/10.1159/000181492.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Chen, T. L., L. Y. Chang, D. A. DiGregorio, A. J. Perlman y Y. F. Huang. "Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells." Endocrinology 133, n.º 3 (septiembre de 1993): 1382–89. http://dx.doi.org/10.1210/endo.133.3.7689954.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Murphy, LJ. "Insulin-like growth factor-binding proteins: functional diversity or redundancy?" Journal of Molecular Endocrinology 21, n.º 2 (1 de octubre de 1998): 97–107. http://dx.doi.org/10.1677/jme.0.0210097.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Zapf, Jürgen. "Physiological role of the insulin-like growth factor binding proteins". European Journal of Endocrinology 132, n.º 6 (junio de 1995): 645–54. http://dx.doi.org/10.1530/eje.0.1320645.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Levitt Katz, Lorraine E., Ron G. Rosenfeld y S. Pinchas Cohen. "Clinical Significance of Insulin-Like Growth Factor Binding Proteins (IGFBPs)". Endocrinologist 5, n.º 1 (enero de 1995): 36–43. http://dx.doi.org/10.1097/00019616-199501000-00006.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Sureshbabu, Angara, Elizabeth Tonner y David J. Flint. "Insulin-like growth factor binding proteins and mammary gland development". International Journal of Developmental Biology 55, n.º 7-8-9 (2011): 781–89. http://dx.doi.org/10.1387/ijdb.113364as.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Lamson, George, Linda C. Giudice y Ron G. Rosenfeld. "Insulin-Like Growth Factor Binding Proteins: Structural and Molecular Relationships". Growth Factors 5, n.º 1 (enero de 1991): 19–28. http://dx.doi.org/10.3109/08977199109000268.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Firth, Sue M. y Robert C. Baxter. "Cellular Actions of the Insulin-Like Growth Factor Binding Proteins". Endocrine Reviews 23, n.º 6 (1 de diciembre de 2002): 824–54. http://dx.doi.org/10.1210/er.2001-0033.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Camacho-Hübner, Cecilia. "Insulin-like growth factor-binding proteins and neoplasia: an overview". Growth Hormone & IGF Research 10 (enero de 2000): S14—S15. http://dx.doi.org/10.1016/s1096-6374(00)90006-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Kim, Ho-Seong, Ron G. Rosenfeld y Youngman Oh. "Biological roles of insulin-like growth factor binding proteins (IGFBPs)". Experimental & Molecular Medicine 29, n.º 2 (junio de 1997): 85–96. http://dx.doi.org/10.1038/emm.1997.13.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Veomett, George E., Lora L. Munger, Gary L. Smith y Judith E. Schollmeyer. "Heterogeneity of insulin-like growth factor binding proteins in swine". Molecular and Cellular Endocrinology 65, n.º 1-2 (agosto de 1989): 49–57. http://dx.doi.org/10.1016/0303-7207(89)90164-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Wetterau, Lawrence A., Michael G. Moore, Kuk-Wah Lee, Melanie L. Shim y Pinchas Cohen. "Novel Aspects of the Insulin-like Growth Factor Binding Proteins". Molecular Genetics and Metabolism 68, n.º 2 (octubre de 1999): 161–81. http://dx.doi.org/10.1006/mgme.1999.2920.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Haugaard, Steen B., Ove Andersen, Birgitte R. Hansen, Hans Ørskov, Ulrik B. Andersen, Sten Madsbad, Johan Iversen y Allan Flyvbjerg. "Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic Human Immunodeficiency Virus-infected patients". Metabolism 53, n.º 12 (diciembre de 2004): 1565–73. http://dx.doi.org/10.1016/j.metabol.2004.06.025.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Lakatos, Peter, Janos Foldes, Zsolt Nagy, Istvan Takacs, Gabor Speer, Csaba Horvath, Subburaman Mohan, David J. Baylink y Paula H. Stern. "Serum Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Proteins, and Bone Mineral Content in Hyperthyroidism". Thyroid 10, n.º 5 (mayo de 2000): 417–23. http://dx.doi.org/10.1089/thy.2000.10.417.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Nakamura, Michio, Shin’ichi Miyamoto, Hiroyuki Maeda, Genichiro Ishii, Takahiro Hasebe, Tsutomu Chiba, Masahiro Asaka y Atsushi Ochiai. "Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability". Biochemical and Biophysical Research Communications 333, n.º 3 (agosto de 2005): 1011–16. http://dx.doi.org/10.1016/j.bbrc.2005.06.010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Yamanaka, Yoshitaka, Elizabeth M. Wilson, Ron G. Rosenfeld y Youngman Oh. "Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins". Journal of Biological Chemistry 272, n.º 49 (5 de diciembre de 1997): 30729–34. http://dx.doi.org/10.1074/jbc.272.49.30729.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Bach, Leon A., Ping Fu y Zhiyong Yang. "Insulin-like growth factor-binding protein-6 and cancer". Clinical Science 124, n.º 4 (31 de octubre de 2012): 215–29. http://dx.doi.org/10.1042/cs20120343.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Resumen
The IGF (insulin-like growth factor) system is essential for physiological growth and it is also implicated in a number of diseases including cancer. IGF activity is modulated by a family of high-affinity IGF-binding proteins, and IGFBP-6 is distinctive because of its marked binding preference for IGF-II over IGF-I. A principal role for IGFBP-6 is inhibition of IGF-II actions, but recent studies have indicated that IGFBP-6 also has IGF-independent effects, including inhibition of angiogenesis and promotion of cancer cell migration. The present review briefly summarizes the IGF system in physiology and disease before focusing on recent studies on the regulation and actions of IGFBP-6, and its potential roles in cancer cells. Given the widespread interest in IGF inhibition in cancer therapeutics, increasing our understanding of the mechanisms underlying the actions of the IGF ligands, receptors and binding proteins, including IGFBP-6, will enhance our ability to develop optimal treatments that can be targeted to the most appropriate patients.
50

Rosenfeld, Ron G., Vivian Hwa, Lisa Wilson, Abel Lopez-Bermejo, Caroline Buckway, Christine Burren, Won Kyu Choi et al. "The Insulin-like Growth Factor Binding Protein Superfamily: New Perspectives". Pediatrics 104, Supplement_5 (1 de octubre de 1999): 1018–21. http://dx.doi.org/10.1542/peds.104.s5.1018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Resumen
The insulin-like growth factor (IGF) binding proteins (IGFBPs) were initially identified as carrier proteins for IGF-I and IGF-II in a variety of biologic fluids. Their presumed function was to protect IGF peptides from degradation and clearance, increase the half-life of the IGFs, and deliver them to appropriate tissue receptors. The concept of IGFBPs as simple carrier proteins has been complicated, however, by a number of observations: 1) the six IGFBPs vary in their tissue expression and their regulation by other hormones and growth factors; 2) the IGFBPs are subjected to proteolytic degradation, thereby altering their affinities for the IGFs; 3) IGFBP-3 and IGFBP-5, in addition to binding IGFs, also can associate with an acid-labile subunit, thereby increasing further the half-life of the IGFs; 4) in addition to modifying the access of IGF peptides to IGF and insulin receptors, several of the IGFBPs may be capable of increasing IGF action; 5) some of the IGFBPs may be capable of IGF-independent regulation of cell growth; 6) some of the IGFBPs are associated with cell membranes or possibly with membrane receptors; and 7) some of the IGFBPs have nuclear recognition sites and may be found within the nucleus. Additionally, a number of cDNAs identified recently have been found to encode proteins that bind IGFs, but with substantially lower affinities than is the case with IGFBPs. The N-terminal regions of the predicted proteins are structurally homologous to the classic IGFBPs, with conservation of the cysteine-rich region. These observations suggest that these low-affinity binders are members of an IGFBP superfamily, capable of regulating cell growth by both IGF-dependent and IGF-independent mechanisms. insulin-like growth factor, insulin-like growth factor binding proteins.
También puede estar interesado en las bibliografías sobre el tema "Insulin-like growth factor-binding proteins" para otros tipos de fuentes:
Tesis Libros

Pasar a la bibliografía